MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcchd.2026.100696

Медицинская библиотека · International journal of cardiology. Congenital heart disease · 2026

Transcatheter closure of perimembranous ventricular septal defect with right coronary cusp prolapse using the Amplatzer Duct Occluder II device: A noval systematic multicenter experience from Iraq.

Salih Aso F, Rasool Mohammed, Al-Ubedi Ammar Ali

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Perimembranous ventricular septal defect (PM-VSD) with right coronary cusp (RCC) prolapse carries a high risk of progressive aortic regurgitation and often lacks a measurable aortic rim, complicating device closure. While surgery remains the standard treatment, transcatheter therapy using the Amplatzer Duct Occluder II (ADO II) offers a less invasive option, though data in Middle Eastern populations are scarce.

OBJECTIVE

To evaluate the feasibility, safety, and intermediate-term outcomes of ADO II closure in PM-VSD patients with RCC prolapse.

METHODS

We conducted a retrospective multicenter study of 29 consecutive patients (mean age: 8.86 ± 5.77 years; 55.2% male) with PM-VSD and RCC prolapse who underwent ADO II closure at two Iraqi cardiac centers (January 2023-November 2024). Inclusion criteria required an effective flow diameter ≤3 mm (left ventricular side), hemodynamic significance (Qp:Qs > 1.5 or left ventricular volume overload), and absence of severe aortic regurgitation or pulmonary hypertension.

RESULTS

Device implantation succeeded in 28 of 29 patients (96.6%). Immediate complete closure occurred in 23 patients (79.3%); 5 had small residual shunts (<2 mm). One patient required surgical conversion. At 6 months, complete closure persisted in 23 patients (79.3%), and 27 patients (93.1%) had favorable outcomes (complete closure or mild valvular regurgitation only). Critically, no new-onset aortic regurgitation developed, and baseline mild aortic insufficiency did not worsen.

CONCLUSION

Transcatheter PM-VSD closure with ADO II is feasible, safe, and effective in carefully selected patients with RCC prolapse-even without a traditional aortic rim. This first systematic multicenter experience from Iraq supports expanding minimally invasive therapy for this high-risk subgroup in resource-constrained settings.

Для цитирования: Salih Aso F, Rasool Mohammed, Al-Ubedi Ammar Ali. Transcatheter closure of perimembranous ventricular septal defect with right coronary cusp prolapse using the Amplatzer Duct Occluder II device: A noval systematic multicenter experience from Iraq.. International journal of cardiology. Congenital heart disease. 2026. DOI: 10.1016/j.ijcchd.2026.100696.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.